Form D · Biotechnology
BioLife4D Corp
Buffalo Grove, IL · CIK 0001714919
Offering snapshot reported Feb 25, 2019 · SEC filing
- Reported sold
- $600K Offering amount: $3M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Jan 21, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 25, 2019 | Initial | $600,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-333470
convertible debt
Source: Form D, filed Feb 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Morris | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
318 Half Day Road, Suite 201
Buffalo Grove, IL, 60089
Buffalo Grove, IL, 60089